This is an 8-week, randomized, double-blind, placebo-controlled, 2 arm, parallel groups,
study of 1-week of treatment with mifepristone (0, 1200 mg/d) given in conjunction with 8
weeks of manual-guided counseling, and a follow-up visit at Week 12.
Phase:
Phase 2
Details
Lead Sponsor:
The Scripps Research Institute
Collaborator:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)